Wat zeggen de experts?

Hieronder vindt u een overzicht met links naar de websites en webinairs van hemato-oncologische beroepsverenigingen en experts met aanbevelingen, adviezen, leidraden, FAQ, etc. rondom hemato-oncologie en COVID-19.


    • HOVON
      Leidraad COVID-19 NVvH-HOVON voor de behandeling van patiënten met hemato-oncologie
      “Uitgangspunt van deze leidraad is om hemato-oncologische behandelingen zoveel als mogelijk te initiëren en te continueren conform de ziekte-specifieke behandelrichtlijnen. Zorg wordt alleen uitgesteld als dat kan zonder de overlevingskansen van patiënten te compromitteren of als ingeschat wordt dat immunosuppressieve behandeling de patiënt in gevaar brengt.”
    • ASCO:
      COVID-19 Clinical Oncology Frequently Asked Questions (FAQs)
      “The following answers to questions we received are based on evidence gathered through a PubMed search of the medical literature, a search of relevant websites with information on infectious diseases (CDC, WHO, IDSA, etc.), and input provided by clinical oncologists and infectious disease experts.”
    • ASH: COVID-19 resources
      “In an effort to serve its members, ASH is maintaining this webpage as a medium to exchange information to assist hematologists in navigating the COVID-19 public health crisis.”
    • ASH: COVID-19 and Multiple Myeloma: Frequently Asked Questions
      “Input from Drs. S Vincent Rajkumar, Michele Cavo, Joseph Mikhail, Maria M Mateos, Graham Jackson, Philippe Moreau, Paul Richardson and Binod Dhakal”
      “The COVID-19 pandemic has brought new challenges to clinical practice and research in oncology. ESMO is reporting on the current situation by news and KOLs experiences, and has gathered useful resources to keep medical oncologists updated.”
    • IMS: Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic


  • IACH Webinar Series: COVID-19 and hematological malignancies: a few practical issues
    Christian Chabannon – Marseille, France; Prof. Mohamad Mohty – Paris, France
    – to protect highly immunosuppressed patients against COVID-19
    – to maintain a state of the art management of the hematologic disease during this
    – to protect healthcare professionals (HCP)
  • IACH Webinar Series: Management of multiple myeloma during COVID 19
    Mohty – Paris, France; Prof. Mateos – Salamanca, Spain

Volgende artikel

Technische hulpmiddelen